{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:24:19Z","timestamp":1790659459825,"version":"4.1.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- RS-2025-00518385"],"award-info":[{"award-number":["NRF- RS-2025-00518385"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF- 2021R1A5A2030333"],"award-info":[{"award-number":["NRF- 2021R1A5A2030333"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.118990","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T20:57:51Z","timestamp":1768251471000},"page":"118990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Peptides for pain sensation and peptides for pain relief: Fighting fire with fire"],"prefix":"10.1016","volume":"195","author":[{"given":"Md. Mahbubur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Won","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4152-3022","authenticated-orcid":false,"given":"Chul-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.biopha.2026.118990_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic Pain Among Adults - United States, 2019-2021","volume":"72","author":"Rikard","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"9","key":"10.1016\/j.biopha.2026.118990_bib2","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/j.pain.0000000000002557","article-title":"A global study of pain prevalence across 52 countries: examining the role of country-level contextual factors","volume":"163","author":"Zimmer","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2026.118990_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122954","article-title":"Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management","volume":"355","author":"Rahman","year":"2024","journal-title":"Life Sci."},{"issue":"24","key":"10.1016\/j.biopha.2026.118990_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415854","article-title":"Diosgenin Exerts Analgesic Effects by Antagonizing the Selective Inhibition of Transient Receptor Potential Vanilloid 1 in a Mouse Model of Neuropathic Pain","volume":"23","author":"Rahman","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/joor.13656","article-title":"Role of neuropeptides in orofacial pain: A literature review","volume":"51","author":"Wang","year":"2024","journal-title":"J. Oral. Rehabil."},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082164","article-title":"General Pathways of Pain Sensation and the Major Neurotransmitters Involved in Pain Regulation","volume":"19","author":"Yam","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","article-title":"Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics","volume":"29","author":"Barman","year":"2023","journal-title":"Int J. Pept. Res Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41392-022-00904-4","article-title":"Therapeutic peptides: current applications and future directions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.biopha.2026.118990_bib9","first-page":"543","article-title":"From Natural Peptides to Market","volume":"50","author":"Schteingart","year":"2017","journal-title":"Annu Rep. Med Chem."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"24","key":"10.1016\/j.biopha.2026.118990_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417504","article-title":"An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein Interactions","volume":"24","author":"Zerihun","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2026.118990_bib12","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jpain.2023.02.002","article-title":"PD-1: A New Candidate Target for Analgesic Peptide Design","volume":"24","author":"Zhao","year":"2023","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052383","article-title":"Molecular Peptide Grafting as a Tool to Create Novel Protein Therapeutics","volume":"28","author":"Komar","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbpa.2004.03.002","article-title":"Developments in peptide and amide synthesis","volume":"8","author":"Albericio","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib15","article-title":"Role of neuropeptides in patients with endometriosis: a literature review","volume":"29","author":"Mosleh","year":"2024","journal-title":"Middle East Fertil. S"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103464","article-title":"Peptide-based drug discovery: Current status and recent advances","volume":"28","author":"Sharma","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2026.118990_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110478","article-title":"Exploring the role of neuropeptides in depression and anxiety","volume":"114","author":"Rana","year":"2022","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2026.118990_bib18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","article-title":"Emerging targets in neuroinflammation-driven chronic pain","volume":"13","author":"Ji","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib19","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2026.118990_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107581","article-title":"Chemokines in chronic pain: cellular and molecular mechanisms and therapeutic potential","volume":"212","author":"Jiang","year":"2020","journal-title":"Pharm. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuron.2019.01.034","article-title":"Substance P and Inflammatory Pain: Getting It Wrong and Right Simultaneously","volume":"101","author":"Navratilova","year":"2019","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib22","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221687","article-title":"Immune drivers of physiological and pathological pain","volume":"221","author":"Jain","year":"2024","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib23","doi-asserted-by":"crossref","first-page":"C728","DOI":"10.1152\/ajpcell.00544.2022","article-title":"The role of PIEZO ion channels in the musculoskeletal system","volume":"324","author":"Savadipour","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib24","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41590-024-02002-9","article-title":"Immune drivers of pain resolution and protection","volume":"25","author":"Hakim","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2026.118990_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117157","article-title":"Irisin alleviates CFA-induced inflammatory pain by modulating macrophage polarization and spinal glial cell activation","volume":"178","author":"Rahman","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12974-021-02131-0","article-title":"The NLRP3 inflammasome: an emerging therapeutic target for chronic pain","volume":"18","author":"Chen","year":"2021","journal-title":"J. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2903","article-title":"BDNF as a biomarker for neuropathic pain: Consideration of mechanisms of action and associated measurement challenges","volume":"13","author":"Thakkar","year":"2023","journal-title":"Brain Behav."},{"key":"10.1016\/j.biopha.2026.118990_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577406","article-title":"The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception","volume":"349","author":"Cappoli","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46402-7","article-title":"Hemokinin-1 is a mediator of chronic restraint stress-induced pain","volume":"13","author":"Borbely","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2026.118990_bib30","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jpain.2022.05.009","article-title":"Spinal CCK1 Receptors Contribute to Somatic Pain Hypersensitivity Induced by Malocclusion via a Reciprocal Neuron-Glial Signaling Cascade","volume":"23","author":"Xiang","year":"2022","journal-title":"J. Pain."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12964-019-0385-8","article-title":"Cholecystokinin type B receptor-mediated inhibition of A-type K(+) channels enhances sensory neuronal excitability through the phosphatidylinositol 3-kinase and c-Src-dependent JNK pathway","volume":"17","author":"Yu","year":"2019","journal-title":"Cell Commun. Signal"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/j.pain.0000000000003013","article-title":"Bradykinin receptor expression and bradykinin-mediated sensitization of human sensory neurons","volume":"165","author":"Yi","year":"2024","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4062\/biomolther.2017.127","article-title":"Depolarizing Effectors of Bradykinin Signaling in Nociceptor Excitation in Pain Perception","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol. Ther. (Seoul. )"},{"issue":"15","key":"10.1016\/j.biopha.2026.118990_bib34","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1111\/bph.16376","article-title":"Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC(1) receptor","volume":"181","author":"Tasma","year":"2024","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12929-016-0280-1","article-title":"Role of vasoactive intestinal peptide in osteoarthritis","volume":"23","author":"Jiang","year":"2016","journal-title":"J. Biomed. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib36","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/1871527314666150429114234","article-title":"Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine","volume":"14","author":"Tajti","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib37","article-title":"Angiotensin-Related Peptides and Their Role in Pain Regulation","volume":"12","author":"Nemoto","year":"2023","journal-title":"Biol. (Basel)"},{"key":"10.1016\/j.biopha.2026.118990_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.571994","article-title":"Angiotensin Type 2 Receptors: Painful, or Not?","volume":"11","author":"Pulakat","year":"2020","journal-title":"Front Pharm."},{"issue":"24","key":"10.1016\/j.biopha.2026.118990_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413619","article-title":"Non-Opioid Peptides Targeting Opioid Effects","volume":"22","author":"Kaczynska","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1-3","key":"10.1016\/j.biopha.2026.118990_bib40","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0014-2999(01)01306-1","article-title":"Neuropathic pain: a possible role for the melanocortin system?","volume":"429","author":"Vrinten","year":"2001","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jpain.2008.09.009","article-title":"Endothelin receptors and pain","volume":"10","author":"Khodorova","year":"2009","journal-title":"J. Pain."},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib42","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1097\/j.pain.0000000000002970","article-title":"Neuropilin-1 is essential for vascular endothelial growth factor A-mediated increase of sensory neuron activity and development of pain-like behaviors","volume":"164","author":"Gomez","year":"2023","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib43","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s13046-021-02127-x","article-title":"VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody","volume":"40","author":"Micheli","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jpain.2009.09.012","article-title":"The nociception induced by glutamate in mice is potentiated by protons released into the solution","volume":"11","author":"Meotti","year":"2010","journal-title":"J. Pain."},{"issue":"9","key":"10.1016\/j.biopha.2026.118990_bib45","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1097\/j.pain.0000000000000973","article-title":"Sensitization of TRPV1 and TRPA1 via peripheral mGluR5 signaling contributes to thermal and mechanical hypersensitivity","volume":"158","author":"Honda","year":"2017","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-018-0616-5","article-title":"Glutamate and Its Receptors as Therapeutic Targets for Migraine","volume":"15","author":"Hoffmann","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.2010.06927.x","article-title":"Chronic prostaglandin E2 treatment induces the synthesis of the pain-related peptide substance P and calcitonin gene-related peptide in cultured sensory ganglion explants","volume":"115","author":"Ma","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2026.118990_bib49","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/TCRM.S139814","article-title":"Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain","volume":"13","author":"Shang","year":"2017","journal-title":"Ther. Clin. Risk Manag"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/biom14010071","article-title":"The Role of the Brain-Derived Neurotrophic Factor in Chronic Pain: Links to Central Sensitization and Neuroinflammation","volume":"14","author":"Xiong","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.celrep.2012.07.014","article-title":"Inflammatory signals enhance piezo2-mediated mechanosensitive currents","volume":"2","author":"Dubin","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2026.118990_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2019.01.015","article-title":"Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms","volume":"147","author":"Hunyady","year":"2019","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.biopha.2026.118990_bib53","doi-asserted-by":"crossref","first-page":"1186279","DOI":"10.3389\/fnmol.2023.1186279","article-title":"Hemokinin-1 induces transcriptomic alterations in pain-related signaling processes in rat primary sensory neurons independent of NK1 tachykinin receptor activation","volume":"16","author":"Takacs-Lovasz","year":"2023","journal-title":"Front Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib54","article-title":"The Cholecystokinin Type 2 Receptor, a Pharmacological Target for Pain Management","volume":"14","author":"Bernard","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.biopha.2026.118990_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2022.100092","article-title":"CCK2 receptors in chronic pain","volume":"11","author":"LaVigne","year":"2022","journal-title":"Neurobiol. Pain."},{"key":"10.1016\/j.biopha.2026.118990_bib56","first-page":"8563202","article-title":"Effect and Mechanism of Endothelin Receptor A Inhibitor BQ-123 Combined with Electroacupuncture on Tibia Cancer Pain in Rats","author":"Tang","year":"2022","journal-title":"Dis. Markers 2022"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib57","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sc.2015.225","article-title":"Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets","volume":"54","author":"Boadas-Vaello","year":"2016","journal-title":"Spinal Cord."},{"key":"10.1016\/j.biopha.2026.118990_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2016.00293","article-title":"Neuroimmune Interaction in the Regulation of Peripheral Opioid-Mediated Analgesia in Inflammation","volume":"7","author":"Hua","year":"2016","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.118990_bib59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2020.08.005","article-title":"Immune cell-mediated opioid analgesia","volume":"227","author":"Machelska","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.biopha.2026.118990_bib60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-540-79090-7_12","article-title":"Cytokine and chemokine regulation of sensory neuron function","volume":"194","author":"Miller","year":"2009","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib61","first-page":"199","article-title":"Pain-resolving immune mechanisms in neuropathic pain","author":"Fiore","year":"2023","journal-title":"Nat. Rev. Neurol. 19(4"},{"key":"10.1016\/j.biopha.2026.118990_bib62","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","article-title":"Advances in Achieving Opioid Analgesia Without Side Effects","volume":"9","author":"Machelska","year":"2018","journal-title":"Front Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030595","article-title":"Spotlight on Nociceptin\/Orphanin FQ Receptor in the Treatment of Pain","volume":"27","author":"El Daibani","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrd2572","article-title":"The nociceptin\/orphanin FQ receptor: a target with broad therapeutic potential","volume":"7","author":"Lambert","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"issue":"46","key":"10.1016\/j.biopha.2026.118990_bib65","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204515119","article-title":"Spinal neuropeptide Y Y1 receptor-expressing neurons are a pharmacotherapeutic target for the alleviation of neuropathic pain","volume":"119","author":"Nelson","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.biopha.2026.118990_bib66","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169554","article-title":"Alleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp","volume":"8","author":"Nelson","year":"2023","journal-title":"JCI Insight"},{"issue":"21","key":"10.1016\/j.biopha.2026.118990_bib67","doi-asserted-by":"crossref","first-page":"12387","DOI":"10.1021\/acs.jmedchem.0c00643","article-title":"Neuropeptide FF and Its Receptors: Therapeutic Applications and Ligand Development","volume":"63","author":"Nguyen","year":"2020","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2026.118990_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuroscience.2024.12.010","article-title":"The dual modulating effects of neuropeptide FF on morphine-induced analgesia at the spinal level","volume":"565","author":"Chen","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2026.118990_bib69","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.neuropharm.2016.02.004","article-title":"Neuropeptide S modulates the amygdaloidal HCN activities (Ih) in rats: Implication in chronic pain","volume":"105","author":"Zhang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2026.118990_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171167","article-title":"Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders","volume":"175","author":"Shirsath","year":"2024","journal-title":"Peptides"},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib71","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jpain.2020.12.004","article-title":"Central Endothelin-1 Confers Analgesia by Triggering Spinal Neuronal Histone Deacetylase 5 (HDAC5) Nuclear Exclusion in Peripheral Neuropathic Pain in Mice","volume":"22","author":"Gu","year":"2021","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050839","article-title":"A New Gal in Town: A Systematic Review of the Role of Galanin and Its Receptors in Experimental Pain","volume":"11","author":"Fonseca-Rodrigues","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib73","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/pr.112.006536","article-title":"Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversity","volume":"67","author":"Lang","year":"2015","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.biopha.2026.118990_bib74","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biopha.2017.03.053","article-title":"A review of the role of orexin system in pain modulation","volume":"90","author":"Razavi","year":"2017","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173029","article-title":"Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice","volume":"874","author":"Matsuura","year":"2020","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib76","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnmol.2018.00248","article-title":"Oxytocin Relieves Neuropathic Pain Through GABA Release and Presynaptic TRPV1 Inhibition in Spinal Cord","volume":"11","author":"Sun","year":"2018","journal-title":"Front Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib77","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.peptides.2011.03.007","article-title":"Oxytocin in the periaqueductal gray participates in pain modulation in the rat by influencing endogenous opiate peptides","volume":"32","author":"Yang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.118990_bib78","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpsychires.2022.05.030","article-title":"Relationship between saliva opiorphin levels, pain threshold, and cutting number in adolescents with non suicidal self injury","volume":"151","author":"Gavcar","year":"2022","journal-title":"J. Psychiatr. Res"},{"issue":"15","key":"10.1016\/j.biopha.2026.118990_bib79","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1523\/JNEUROSCI.4703-13.2014","article-title":"Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity","volume":"34","author":"Gong","year":"2014","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib80","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/s12276-024-01342-8","article-title":"GLP-1 and its derived peptides mediate pain relief through direct TRPV1 inhibition without affecting thermoregulation","volume":"56","author":"Go","year":"2024","journal-title":"Exp. Mol. Med"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51140-w","article-title":"Effects of ghrelin on pGSK-3beta and beta-catenin expression when protects against neuropathic pain behavior in rats challenged with chronic constriction injury","volume":"9","author":"Peng","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib82","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.21873\/invivo.13548","article-title":"Ghrelin Induces the Production of Hypothalamic NPY Through the AMPK-mTOR Pathway to Alleviate Cancer-induced Bone Pain","volume":"38","author":"Xu","year":"2024","journal-title":"Vivo"},{"key":"10.1016\/j.biopha.2026.118990_bib83","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.peptides.2013.03.004","article-title":"In vivo characterization of the effects of ghrelin on the modulation of acute pain at the supraspinal level in mice","volume":"43","author":"Wei","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.118990_bib84","doi-asserted-by":"crossref","DOI":"10.1177\/17448069221108965","article-title":"Analgesic effect of gastrin-releasing peptide in the dorsal horn","volume":"18","author":"Saeki","year":"2022","journal-title":"Mol. Pain."},{"key":"10.1016\/j.biopha.2026.118990_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116392","article-title":"Specific transcription factors Ascl1 and Lhx6 attenuate diabetic neuropathic pain by modulating spinal neuroinflammation and microglial activation in mice","volume":"173","author":"Hwang","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib86","article-title":"Modulation of pain sensitivity by Ascl1-and Lhx6-dependent GABAergic neuronal function in streptozotocin diabetic mice","author":"Hwang","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.118990_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115800","article-title":"Current status of GABA receptor subtypes in analgesia","volume":"168","author":"Qian","year":"2023","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2023.110691","article-title":"Role of GABAergic system in the comorbidity of pain and depression","volume":"200","author":"Yang","year":"2023","journal-title":"Brain Res Bull."},{"issue":"14","key":"10.1016\/j.biopha.2026.118990_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411236","article-title":"Glycine: The Smallest Anti-Inflammatory Micronutrient","volume":"24","author":"Aguayo-Ceron","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib90","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","article-title":"Glycine transport inhibitors for the treatment of pain","volume":"35","author":"Vandenberg","year":"2014","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib91","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1134\/S1068162022020157","article-title":"Peptide Hormones in Medicine: A 100-Year History","volume":"48","author":"Martinovich","year":"2022","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.biopha.2026.118990_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.697586","article-title":"Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives","volume":"8","author":"Cabri","year":"2021","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.biopha.2026.118990_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.foohum.2024.100294","article-title":"Harvesting bioactive peptides from sustainable protein sources: Unveiling technological and functional properties through in silico analyses","volume":"2","author":"Ozturk","year":"2024","journal-title":"Food Humanit."},{"issue":"9","key":"10.1016\/j.biopha.2026.118990_bib94","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092714","article-title":"Peptides as Therapeutic Agents for Inflammatory-Related Diseases","volume":"19","author":"La Manna","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102044","article-title":"Integrative approaches in cryogenic electron microscopy: Recent advances in structural biology and future perspectives","volume":"24","author":"Banerjee","year":"2021","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib96","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163735","article-title":"A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents","volume":"133","author":"He","year":"2023","journal-title":"J. Clin. Invest"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103950","article-title":"Peptide-derived ligands for the discovery of safer opioid analgesics","volume":"29","author":"Eliasof","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2026.118990_bib98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.omtn.2018.02.007","article-title":"Gene Therapy for Neuropathic Pain through siRNA-IRF5 Gene Delivery with Homing Peptides to Microglia","volume":"11","author":"Terashima","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"31","key":"10.1016\/j.biopha.2026.118990_bib99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204114119","article-title":"An analgesic peptide H-20 attenuates chronic pain via the PD-1 pathway with few adverse effects","volume":"119","author":"Zhao","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jpain.2012.03.008","article-title":"Cyclotraxin-B, a new TrkB antagonist, and glial blockade by propentofylline, equally prevent and reverse cold allodynia induced by BDNF or partial infraorbital nerve constriction in mice","volume":"13","author":"Constandil","year":"2012","journal-title":"J. Pain."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00540-012-1377-7","article-title":"Effects of TrkA inhibitory peptide on cancer-induced pain in a mouse melanoma model","volume":"26","author":"Tabata","year":"2012","journal-title":"J. Anesth."},{"issue":"731","key":"10.1016\/j.biopha.2026.118990_bib102","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abm6046","article-title":"Structural analysis of TrkA mutations in patients with congenital insensitivity to pain reveals PLCgamma as an analgesic drug target","volume":"15","author":"Moraes","year":"2022","journal-title":"Sci. Signal"},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1526-5900(03)00636-9","article-title":"Acute pancreatitis results in referred mechanical hypersensitivity and neuropeptide up-regulation that can be suppressed by the protein kinase inhibitor k252a","volume":"4","author":"Winston","year":"2003","journal-title":"J. Pain."},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib104","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.npep.2007.09.005","article-title":"Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance","volume":"41","author":"Lungu","year":"2007","journal-title":"Neuropeptides"},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s000110300067","article-title":"Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats","volume":"52","author":"Yamaguchi-Sase","year":"2003","journal-title":"Inflamm. Res"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib106","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuropharm.2008.10.008","article-title":"Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain","volume":"56","author":"Hama","year":"2009","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib107","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1476-5381.2010.00824.x","article-title":"Spinal or systemic TY005, a peptidic opioid agonist\/neurokinin 1 antagonist, attenuates pain with reduced tolerance","volume":"161","author":"Largent-Milnes","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1756-6606-5-19","article-title":"Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats","volume":"5","author":"Cao","year":"2012","journal-title":"Mol. Brain"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib109","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bcp.12099","article-title":"Netazepide, a gastrin\/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects","volume":"76","author":"Boyce","year":"2013","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib110","doi-asserted-by":"crossref","unstructured":"C.A. Salvatore, E.L. Moore, A. Calamari, J.J. Cook, M.S. Michener, S. O\u2032Malley, P.J. Miller, C. Sur, D.L. Williams, Jr., Z. Zeng, A. Danziger, J.J. Lynch, C.P. Regan, J.F. Fay, Y.S. Tang, C.C. Li, N.T. Pudvah, R.B. White, I.M. Bell, S.N. Gallicchio, S.L. Graham, H.G. Selnick, J.P. Vacca, S.A. Kane, Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist, J Pharmacol Exp Ther 333(1) (2010) 152-160.","DOI":"10.1124\/jpet.109.163816"},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib111","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib112","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.joca.2019.07.013","article-title":"A tale of two TrkA inhibitor trials: same target, divergent results","volume":"27","author":"Walsh","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib113","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41598-018-37585-5","article-title":"A C-terminal cysteine residue is required for peptide-based inhibition of the NGF\/TrkA interaction at nM concentrations: implications for peptide-based analgesics","volume":"9","author":"Poole","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.biopha.2026.118990_bib114","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1073\/pnas.96.7.4067","article-title":"A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat","volume":"96","author":"Debeir","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020216","article-title":"hNGF Peptides Elicit the NGF-TrkA Signalling Pathway in Cholinergic Neurons and Retain Full Neurotrophic Activity in the DRG Assay","volume":"10","author":"Triaca","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/ALN.0b013e31821b1ac5","article-title":"Antagonism of nerve growth factor-TrkA signaling and the relief of pain","volume":"115","author":"Mantyh","year":"2011","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.biopha.2026.118990_bib117","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1016\/j.ymthe.2024.08.022","article-title":"A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease","volume":"32","author":"Fonseca-Gomes","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.biopha.2026.118990_bib118","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.2147\/OTT.S158570","article-title":"Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomiting","volume":"11","author":"Navari","year":"2018","journal-title":"Onco Targets Ther."},{"issue":"392","key":"10.1016\/j.biopha.2026.118990_bib119","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3447","article-title":"Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief","volume":"9","author":"Jensen","year":"2017","journal-title":"Sci. Transl. Med"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.peptides.2003.06.003","article-title":"Beneficial effect of chronic treatment with the selective bradykinin B1 receptor antagonists, R-715 and R-954, in attenuating streptozotocin-diabetic thermal hyperalgesia in mice","volume":"24","author":"Gabra","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.118990_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106305","article-title":"Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation","volume":"82","author":"Marceau","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib122","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1254\/fpj.119.45","article-title":"Bradykinin antagonist: current status and perspective","volume":"119","author":"Hirayama","year":"2002","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"10","key":"10.1016\/j.biopha.2026.118990_bib123","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/mt.2011.42","article-title":"Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain","volume":"19","author":"D'Mello","year":"2011","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0031-6989(87)90031-2","article-title":"Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK","volume":"19","author":"Makovec","year":"1987","journal-title":"Pharm. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib125","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0006-8993(90)90927-4","article-title":"Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment","volume":"516","author":"Kellstein","year":"1990","journal-title":"Brain Res"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib126","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.drudis.2020.05.008","article-title":"CCK(2)R antagonists: from SAR to clinical trials","volume":"25","author":"Novak","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib127","first-page":"325","article-title":"Food-Derived Bioactive Peptides: A Promising Substitute to Chemosynthetic Drugs Against the Dysregulated Renin-Angiotensin System in COVID-19 Patients","volume":"11","author":"Mahamud","year":"2021","journal-title":"J. Biol. Act. Prod. Nat."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0143-4179(91)90104-Q","article-title":"An analogue of growth hormone releasing factor (GRF), (Ac-Try1, D-Phe2)-GRF-(1-29), specifically antagonizes the facilitation of the flexor reflex induced by intrathecal vasoactive intestinal peptide in rat spinal cord","volume":"18","author":"Xu","year":"1991","journal-title":"Neuropeptides"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib129","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0165-6147(99)01340-1","article-title":"VIP and PACAP: very important in pain?","volume":"20","author":"Dickinson","year":"1999","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.118990_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106200","article-title":"tLyp-1: A peptide suitable to target NRP-1 receptor","volume":"130","author":"Larue","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib131","article-title":"The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib132","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12951-021-01198-4","article-title":"Conjugation of VEGFR1\/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity","volume":"20","author":"Zanjanchi","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.biopha.2026.118990_bib133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mcn.2014.02.007","article-title":"Over-expression of astrocytic ET-1 attenuates neuropathic pain by inhibition of ERK1\/2 and Akt(s) via activation of ETA receptor","volume":"60","author":"Hung","year":"2014","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.biopha.2026.118990_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.170943","article-title":"Synergistic interaction between DAMGO-NH(2) and NOP01 in peripherally acting antinociception in two mouse models of formalin pain","volume":"161","author":"Li","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.biopha.2026.118990_bib135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuropharm.2015.12.024","article-title":"Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine","volume":"105","author":"Zadina","year":"2016","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib136","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.jpain.2017.08.007","article-title":"Novel Endomorphin Analogs Are More Potent and Longer-Lasting Analgesics in Neuropathic, Inflammatory, Postoperative, and Visceral Pain Relative to Morphine","volume":"18","author":"Feehan","year":"2017","journal-title":"J. Pain."},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib137","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/pm\/pnz122","article-title":"Dilemma of Addiction and Respiratory Depression in the Treatment of Pain: A Prototypical Endomorphin as a New Approach","volume":"21","author":"Webster","year":"2020","journal-title":"Pain. Med"},{"issue":"44","key":"10.1016\/j.biopha.2026.118990_bib138","doi-asserted-by":"crossref","first-page":"22353","DOI":"10.1073\/pnas.1908662116","article-title":"A tetrapeptide class of biased analgesics from an Australian fungus targets the micro-opioid receptor","volume":"116","author":"Dekan","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.118990_bib139","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fphar.2020.00188","article-title":"Functional Selectivity and Antinociceptive Effects of a Novel KOPr Agonist","volume":"11","author":"Bedini","year":"2020","journal-title":"Front Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-5793(01)03042-3","article-title":"Rubiscolin, a delta selective opioid peptide derived from plant Rubisco","volume":"509","author":"Yang","year":"2001","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib141","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1124\/jpet.110.172866","article-title":"In vivo characterization of MMP-2200, a mixed delta\/mu opioid agonist, in mice","volume":"336","author":"Lowery","year":"2011","journal-title":"J. Pharm. Exp. Ther."},{"issue":"37","key":"10.1016\/j.biopha.2026.118990_bib142","doi-asserted-by":"crossref","first-page":"E5511","DOI":"10.1073\/pnas.1605295113","article-title":"A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","volume":"113","author":"Ding","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.biopha.2026.118990_bib143","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1111\/bph.15165","article-title":"Multifunctional opioid receptor agonism and antagonism by a novel macrocyclic tetrapeptide prevents reinstatement of morphine-seeking behaviour","volume":"177","author":"Brice-Tutt","year":"2020","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib144","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bph.14848","article-title":"The multifunctional peptide DN-9 produced peripherally acting antinociception in inflammatory and neuropathic pain via mu- and kappa-opioid receptors","volume":"177","author":"Xu","year":"2020","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.017","article-title":"Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance","volume":"108","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/j.biopha.2026.118990_bib146","doi-asserted-by":"crossref","first-page":"9042","DOI":"10.1021\/acs.jmedchem.1c00158","article-title":"Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the kappa-Opioid Receptor for the Treatment of Chronic Abdominal Pain","volume":"64","author":"Muratspahic","year":"2021","journal-title":"J. Med Chem."},{"key":"10.1016\/j.biopha.2026.118990_bib147","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuropharm.2017.03.012","article-title":"RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents","volume":"118","author":"Elhabazi","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib148","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.114.219063","article-title":"Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models","volume":"352","author":"Metcalf","year":"2015","journal-title":"J. Pharm. Exp. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib149","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pbb.2012.09.003","article-title":"Antagonism of the neuropeptide S receptor with RTI-118 decreases cocaine self-administration and cocaine-seeking behavior in rats","volume":"103","author":"Schmoutz","year":"2012","journal-title":"Pharm. Biochem Behav."},{"key":"10.1016\/j.biopha.2026.118990_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109743","article-title":"RTI-263, a biased neuropeptide S receptor agonist that retains an anxiolytic effect, attenuates cocaine-seeking behavior in rats","volume":"241","author":"Huang","year":"2023","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib152","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bja.2023.12.032","article-title":"Effects of the orexin receptor 2 agonist danavorexton on emergence from general anaesthesia and opioid-induced sedation, respiratory depression, and analgesia in rats and monkeys","volume":"132","author":"Suzuki","year":"2024","journal-title":"Br. J. Anaesth."},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib153","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1021\/acs.jmedchem.1c00841","article-title":"Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med Chem."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib154","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1021\/acsmedchemlett.5b00447","article-title":"Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of NaV1.7 with Efficacy in Rodent Pain Models","volume":"7","author":"Focken","year":"2016","journal-title":"ACS Med Chem. Lett."},{"issue":"11","key":"10.1016\/j.biopha.2026.118990_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/toxics11110893","article-title":"Carbetocin Inhibits Behavioral Sensitization to Ethanol in Male and Female Mice, Independent of Corticosterone Levels","volume":"11","author":"Costa","year":"2023","journal-title":"Toxics"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib156","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/ejp.1781","article-title":"Anti-nociceptive effects of oxytocin receptor modulation in healthy volunteers-A randomized, double-blinded, placebo-controlled study","volume":"25","author":"Biurrun Manresa","year":"2021","journal-title":"Eur. J. Pain."},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib157","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.neuron.2016.01.041","article-title":"A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing","volume":"89","author":"Eliava","year":"2016","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib158","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cmdc.201100574","article-title":"Generating orally active galanin analogues with analgesic activities","volume":"7","author":"Robertson","year":"2012","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.biopha.2026.118990_bib159","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s11064-017-2229-5","article-title":"Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2","volume":"42","author":"Metcalf","year":"2017","journal-title":"Neurochem. Res"},{"issue":"19","key":"10.1016\/j.biopha.2026.118990_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910848","article-title":"Galanin(1-15) Potentiates the Antidepressant-like Effects Induced by Escitalopram in a Rat Model of Depression","volume":"22","author":"Garcia-Duran","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1-3","key":"10.1016\/j.biopha.2026.118990_bib161","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0167-0115(00)00127-0","article-title":"Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation","volume":"95","author":"Xu","year":"2000","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib162","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jcsm.13191","article-title":"Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia","volume":"14","author":"Herodes","year":"2023","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib163","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00268-011-1335-9","article-title":"Ghrelin agonist TZP-101\/ulimorelin accelerates gastrointestinal recovery independently of opioid use and surgery type: covariate analysis of phase 2 data","volume":"36","author":"Bochicchio","year":"2012","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib164","doi-asserted-by":"crossref","first-page":"E1007","DOI":"10.1152\/ajpendo.00109.2005","article-title":"Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle","volume":"289","author":"Granado","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib165","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/1735-5362.207201","article-title":"Comparative effects of chronic administrations of gabapentin, pregabalin and baclofen on rat memory using object recognition test","volume":"12","author":"Salimzade","year":"2017","journal-title":"Res Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib166","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.bbrc.2018.10.154","article-title":"Augmentation of endogenous GABA pool size induced by Magainin II peptide","volume":"506","author":"Boostan","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"key":"10.1016\/j.biopha.2026.118990_bib167","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbrc.2022.01.126","article-title":"Differentiation of PANC-1 ductal cells to beta-like cells via cellular GABA modulation by Magainin and CPF-7 peptides","volume":"597","author":"Heydari","year":"2022","journal-title":"Biochem Biophys. Res Commun."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib168","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neuropharm.2009.04.014","article-title":"The selectivity of conantokin-G for ion channel inhibition of NR2B subunit-containing NMDA receptors is regulated by amino acid residues in the S2 region of NR2B","volume":"57","author":"Sheng","year":"2009","journal-title":"Neuropharmacology"},{"issue":"Pt 1","key":"10.1016\/j.biopha.2026.118990_bib169","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1113\/jphysiol.2001.013147","article-title":"Beta-alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro","volume":"539","author":"Mori","year":"2002","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bph.13652","article-title":"The peptide Phalpha1beta, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice","volume":"174","author":"Tonello","year":"2017","journal-title":"Br. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib171","doi-asserted-by":"crossref","first-page":"241a","DOI":"10.1016\/j.bpj.2023.11.1531","article-title":"A synthetic peptide, designed from neurotoxin GsMTx4, reduces mechanical and neuropathic pain via TRPV4","volume":"123","author":"Ke","year":"2024","journal-title":"Biophys. J."},{"issue":"29","key":"10.1016\/j.biopha.2026.118990_bib172","doi-asserted-by":"crossref","first-page":"6295","DOI":"10.1021\/bi200770q","article-title":"The mechanosensitive ion channel Piezo1 is inhibited by the peptide GsMTx4","volume":"50","author":"Bae","year":"2011","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib173","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cub.2014.01.013","article-title":"A tarantula-venom peptide antagonizes the TRPA1 nociceptor ion channel by binding to the S1-S4 gating domain","volume":"24","author":"Gui","year":"2014","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib174","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coph.2007.09.001","article-title":"Acid-sensing ion channels (ASICs) as pharmacological targets for neurodegenerative diseases","volume":"8","author":"Xiong","year":"2008","journal-title":"Curr. Opin. Pharm."},{"issue":"47","key":"10.1016\/j.biopha.2026.118990_bib175","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305215120","article-title":"A peptidomimetic modulator of the Ca(V)2.2 N-type calcium channel for chronic pain","volume":"120","author":"Gomez","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib176","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/bph.16309","article-title":"An orally available Ca(v)2.2 calcium channel inhibitor for the treatment of neuropathic pain","volume":"181","author":"Kutzsche","year":"2024","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib177","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177429","article-title":"C2230, a preferential use- and state-dependent CaV2.2 channel blocker, mitigates pain behaviors across multiple pain models","volume":"135","author":"Tang","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"20","key":"10.1016\/j.biopha.2026.118990_bib178","doi-asserted-by":"crossref","first-page":"8520","DOI":"10.1073\/pnas.0611364104","article-title":"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat","volume":"104","author":"Jarvis","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.biopha.2026.118990_bib179","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/j.pain.0000000000002112","article-title":"Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain","volume":"162","author":"Beckley","year":"2021","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib180","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/pharmrev.123.000923","article-title":"Conotoxins Targeting Voltage-Gated Sodium Ion Channels","volume":"76","author":"Pei","year":"2024","journal-title":"Pharm. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib181","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ejp.2059","article-title":"Spinal voltage-gated potassium channel Kv1.3 contributes to neuropathic pain via the promotion of microglial M1 polarization and activation of the NLRP3 inflammasome","volume":"27","author":"Yuan","year":"2023","journal-title":"Eur. J. Pain."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib182","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2211977120","article-title":"A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritis","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.118990_bib183","doi-asserted-by":"crossref","DOI":"10.1590\/\/1678-9199-jvatitd-2019-0043","article-title":"Jingzhaotoxin-X, a gating modifier of Kv4.2 and Kv4.3 potassium channels purified from the venom of the Chinese tarantula Chilobrachys jingzhao","volume":"26","author":"Deng","year":"2020","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"issue":"14","key":"10.1016\/j.biopha.2026.118990_bib184","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411513","article-title":"kappaO-SrVIA Conopeptide, a Novel Inhibitor Peptide for Two Members of the Human EAG Potassium Channel Family","volume":"24","author":"Martinez-Hernandez","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib185","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/jnc.13891","article-title":"Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3","volume":"140","author":"Schwartz","year":"2017","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib186","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.xphs.2021.11.003","article-title":"Blockade of Microglial Kv1.3 Potassium Channels by the Peptide HsTX1[R14A] Attenuates Lipopolysaccharide-mediated Neuroinflammation","volume":"111","author":"Nicolazzo","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2026.118990_bib187","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ymthe.2024.12.036","article-title":"Potent painkiller from spider venom antagonizes P2X3 receptors without dysgeusia","volume":"33","author":"Oparin","year":"2025","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2026.118990_bib188","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/ana.21949","article-title":"Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain","volume":"67","author":"Grishin","year":"2010","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib189","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41467-018-03728-5","article-title":"The ASIC3\/P2X3 cognate receptor is a pain-relevant and ligand-gated cationic channel","volume":"9","author":"Stephan","year":"2018","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.biopha.2026.118990_bib190","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1523\/JNEUROSCI.0323-08.2008","article-title":"P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury","volume":"28","author":"Tozaki-Saitoh","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biopha.2026.118990_bib191","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108453","article-title":"Mambalgin-1 pain-relieving peptide locks the hinge between alpha4 and alpha5 helices to inhibit rat acid-sensing ion channel 1a","volume":"185","author":"Salinas","year":"2021","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib192","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021581118","article-title":"Mambalgin-3 potentiates human acid-sensing ion channel 1b under mild to moderate acidosis: Implications as an analgesic lead","volume":"118","author":"Cristofori-Armstrong","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib193","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1111\/bph.14089","article-title":"Inhibition of acid-sensing ion channels by diminazene and APETx2 evoke partial and highly variable antihyperalgesia in a rat model of inflammatory pain","volume":"175","author":"Lee","year":"2018","journal-title":"Br. J. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2026.118990_bib194","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.tips.2021.09.008","article-title":"Acid-sensing ion channels as potential therapeutic targets","volume":"42","author":"Heusser","year":"2021","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2026.118990_bib195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.peptides.2014.03.016","article-title":"Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats","volume":"56","author":"Toniolo","year":"2014","journal-title":"Peptides"},{"issue":"51","key":"10.1016\/j.biopha.2026.118990_bib196","doi-asserted-by":"crossref","first-page":"20588","DOI":"10.1073\/pnas.0706980105","article-title":"Hemopressin is an inverse agonist of CB1 cannabinoid receptors","volume":"104","author":"Heimann","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.118990_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108178","article-title":"VF-13, a chimeric peptide of VD-hemopressin(alpha) and neuropeptide VF, produces potent antinociception with reduced cannabinoid-related side effects","volume":"175","author":"Xu","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib198","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12974-020-02066-y","article-title":"Suppression of TLR4-MyD88 signaling pathway attenuated chronic mechanical pain in a rat model of endometriosis","volume":"18","author":"Su","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.118990_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112918","article-title":"Novel analgesic peptide derived from Cinobufacini injection suppressing inflammation and pain via ERK1\/2\/COX-2 pathway","volume":"141","author":"Guo","year":"2024","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.biopha.2026.118990_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2017.10.016","article-title":"Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice","volume":"300","author":"Tonkin","year":"2018","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib201","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-021-02155-6","article-title":"Oxidative stress induced by NOX2 contributes to neuropathic pain via plasma membrane translocation of PKCepsilon in rat dorsal root ganglion neurons","volume":"18","author":"Xu","year":"2021","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2026.118990_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176058","article-title":"Wnt signaling is involved in crotalphine-induced analgesia in a rat model of neuropathic pain","volume":"959","author":"Hosch","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116067","article-title":"Diosmetin alleviates neuropathic pain by regulating the Keap1\/Nrf2\/NF-kappaB signaling pathway","volume":"170","author":"Zhao","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154598","article-title":"New advances in Nrf2-mediated analgesic drugs","volume":"110","author":"Luan","year":"2023","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib205","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","article-title":"The Jak\/STAT pathway: A focus on pain in rheumatoid arthritis","volume":"51","author":"Simon","year":"2021","journal-title":"Semin Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2026.118990_bib206","article-title":"TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib207","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00210-010-0536-3","article-title":"Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor","volume":"382","author":"Selvatici","year":"2010","journal-title":"Naunyn Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2026.118990_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2022.102176","article-title":"Peptide WCPFSRSF alleviates sleep deprivation-induced memory impairment by inhibiting neuroinflammation and modulating IL-6\/JAK\/STAT signaling pathway","volume":"50","author":"Zhang","year":"2022","journal-title":"Food Biosci."},{"key":"10.1016\/j.biopha.2026.118990_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.924178","article-title":"Moringa oleifera Lam. Peptide Remodels Intestinal Mucosal Barrier by Inhibiting JAK-STAT Activation and Modulating Gut Microbiota in Colitis","volume":"13","author":"Hong","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2026.118990_bib210","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.ejmech.2017.10.052","article-title":"Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency","volume":"143","author":"Lu","year":"2018","journal-title":"Eur. J. Med Chem."},{"issue":"7","key":"10.1016\/j.biopha.2026.118990_bib211","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1248\/cpb.51.759","article-title":"Synthesis and antinociceptive activity of orally active opioid peptides: improvement of oral bioavailability by esterification","volume":"51","author":"Ogawa","year":"2003","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"8","key":"10.1016\/j.biopha.2026.118990_bib212","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00044-024-03269-1","article-title":"Peptide-based therapeutics: challenges and solutions","volume":"33","author":"Pereira","year":"2024","journal-title":"Med Chem. Res"},{"issue":"3","key":"10.1016\/j.biopha.2026.118990_bib213","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030264","article-title":"Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and alpha-MSH Realms","volume":"14","author":"Musaimi","year":"2024","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.biopha.2026.118990_bib214","doi-asserted-by":"crossref","DOI":"10.1002\/psc.70017","article-title":"Cyclization of the Analgesic \u03b1-Conotoxin Vc1.1 With a Non-Natural Linker: Effects on Structure, Stability, and Bioactivity","volume":"31","author":"Zhang","year":"2025","journal-title":"J. Pept. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:48:25Z","timestamp":1777574905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":214,"alternative-id":["S0753332226000223"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.118990","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptides for pain sensation and peptides for pain relief: Fighting fire with fire","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.118990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118990"}}